OKYO Pharma (OKYO), an ophthalmology-focused bio-pharmaceutical company, announced that it has received clearance of its Investigational New Drug (IND) application from the FDA to initiate a Phase 2, first-in-human, clinical
OKYO Pharma (OKYO), an ophthalmology-focused bio-pharmaceutical company, announced that it has received clearance of its Investigational New Drug (IND) application from the FDA to initiate a Phase 2, first-in-human, clinical
Completed Phase Two Drilling Assays Confirm Consistent High-Grade Graphite Intersections
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Dax 40, Dow, Bitcoin,
Overall, it was a decent week for London’s junior markets, with AIM100 up 0.39% to 4,034 though it lagged against the Footsie, which rose more than 0.8%.
Europa Oil & Gas (EOG), the oil and gas production company, announced its audited final results for the 12-month period ended 31 July 2022. The company said that revenue more
GreenRoc Mining Plc (AIM: GROC), a company focused on the development of critical minerals projects in Greenland, is pleased to announce the first batch of assay results from drill core from
GreenRoc Passes Key Milestone Following Successful Spheronisation Tests
AfriTin Mining (ATM), an African technology metals mining company, announced results for the lithium and tantalum infill drilling programme at the company’s flagship operation, the Uis Mine.
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection of charts is FTSE 100, Bitcoin, Eve, GreenRoc, Guild,
Emmerson (EML), the Moroccan focused potash development company, announce it has reached agreement with Global Sustainable Minerals and Gold Quay Capital Pte Ltd to extend the commitment period for the
The momentum behind the contract wins at Open Orphan (ORPH), a specialist contract research organisation, grows not only in frequency, but magnitude.